Interactions of Hyperthermia with Hypoxic Cell Sensitisers

  • N. M. Bleehen
  • M. I. Walton
  • P. Workman
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 109)


The role of hypoxic cell radiosensitisers has been extensively investigated for the past two decades. Efficacy in experimental models awaits validation in the clinic, but newer drugs currently entering clinical trial show considerable promise. Preferential hypoxic cell cytotoxicity by these electron-affinic agents was demonstrated about 10 years ago. Soon after the enhancement of this cytotoxity by hyperthermia was reported in cells in monolayer culture (Stratford and Adams 1977; Hall et al. 1977), multicellular tumour spheroids (Morgan and Bleehen 1981) and experimental tumours in vivo (Bleehen et al. 1977a; George et al. 1977). The purpose of this paper is briefly to review the topic of the interaction of heat with some hypoxic cell sensitisers. In addition we will also present some of our recent data on aspects of the pharmacology of this combination of treatment modalities. This updates reviews presented at the 2nd International Hyperthermia Symposium in Essen (Bleehen et al. 1978) and more recently by Adams et al. (1982).


Plasma Clearance Hypoxic Cell Multicellular Tumour Spheroid Local Hyperthermia Hypoxic Fraction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams GE, Stratford IJ, Rajaratnam S (1982) Interaction of the cytotoxic and sensitizing effects of electron-affinic drugs and hyperthermia. Natl Cancer Inst Monogr 61: 27–35PubMedGoogle Scholar
  2. Bleehen NM (1983) Heat and drugs: current status of thermo-chemotherapy. In: Steel GG, Adams GE, Peckham MJ (eds) The biological basis of radiotherapy. Elsevier, Amsterdam, pp 321–332Google Scholar
  3. Bleehen NM, Morgan JE (1982) Interaction between misonidazole, hyperthermia, and some cytotoxic drugs on multicellular tumour spheroids. In: Karcher KH et al. (eds) Progress in radio-oncology II, Raven, New York, pp 457–464Google Scholar
  4. Bleehen NM, Honess DJ, Morgan JE (1977 a) Interaction of hyperthermia and the hypoxiccell sensitizer Ro 07-0582 on the EMT6 mouse tumour. Br J Cancer 35: 299–306PubMedCrossRefGoogle Scholar
  5. Bleehen NM, Honess DJ, Morgan JE (1977 b) Interaction of the hypoxic cell sensitizer Ro 07-0582 and hyperthermia on EMT6 tumour cells in vitro and in vivo. In: Radiobiological research and radiotherapy, vol 1. International Atomic Energy Agency, Vienna, pp 211–220Google Scholar
  6. Bleehen NM, Honess DJ, Morgan JE (1978) The combined effects of hyperthermia and hypoxic cell sensitizers. In: Streffer C (ed) Cancer therapy by hyperthermia and radiation. Urban und Schwarzenberg, Munich, pp 62–71Google Scholar
  7. Brown DM, Cohen MS, Sagerman RH, Gonzales-Mendez R, Hahn GM, Brown JM (1983) Influence of heat on the intracellular uptake and radiosensitisation of 2-nitroimidazole hypoxic cell sensitisers in vitro. Cancer Res 43: 3138–3142PubMedGoogle Scholar
  8. Brown JM, Workman P (1980) Partition coefficient as a guide to the development of radiosensitizers which are less toxic that misonidazole. Radiat Res 82: 171–190PubMedCrossRefGoogle Scholar
  9. Coleman CN, Urtasun RC, Wasserman TD, Hancock S, Harris JW, Halsey J, Hirst VK (1984) Initial report of the phase 1 trial of the hypoxic cell radiosensitizer SR 2508. Int J Radiat Oncol Biol Phys 10: 1749–1753PubMedCrossRefGoogle Scholar
  10. Daly JM, Wang YM, Kapelanski D, Howard-Frazier O (1984) Systemic thermochemotherapy, toxicity and plasma pharmacokinetics of methotrexate and doxorubicin. J Surg Res 37: 343–347PubMedCrossRefGoogle Scholar
  11. Denekamp J (1978) Cytotoxicity and radiosensitization in mouse and man. Br J Radiol 57: 636–637CrossRefGoogle Scholar
  12. Dennis MF, Stratford MRL, Wardman P, Watts ME (1985) Cellular uptake of misonidazole analogues with acidic or basic functions. Int J Radiat Biol 47: 629–643CrossRefGoogle Scholar
  13. George KC, Hirst DG, McNally NJ (1977) Effect of hyperthermia on the cytotoxicity of the radiosensitizer Ro 07-0582 in a solid mouse tumour. Br J Cancer 35: 372–375PubMedCrossRefGoogle Scholar
  14. Gomer CJ, Johnson RJ (1979) Relationship between misonidazole toxicity and core temperature in C3H mice. Radiat Res 78: 329–333PubMedCrossRefGoogle Scholar
  15. Hall EJ, Astor M, Geard C, Biaglow J (1977) Cytotoxicity of Ro 07-0582; enhancement by hyperthermia and protection by cyteamine. Br J Cancer 35: 809–815PubMedCrossRefGoogle Scholar
  16. Honess DJ, Bleehen NM (1982) Sensitivity of normal mouse marrow and RIF-1 tumour to hyperthermia combined with cyclophosphamide or BCNU: a lack of therapeutic gain. Br J Cancer 46: 236–248PubMedCrossRefGoogle Scholar
  17. Honess DJ, Morgan JE, Bleehen NM (1978) The hyperthermic potentiation of the cytotoxic effect of misonidazole on the EMT6 mouse tumour: relevance of in vitro measurement of in vivo effect. Br J Cancer 37 [Suppl III]: 173–177Google Scholar
  18. Honess DJ, Workman P, Morgan JE, Bleehen NM (1980) Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse. Br J Cancer 41: 529–540PubMedCrossRefGoogle Scholar
  19. Honess DJ, Donaldson J, Workman P, Bleehen NM (1985) The effects of systemic hyperthermia on melphalan pharmacokinetics in mice. Br J Cancer 51: 77–84PubMedCrossRefGoogle Scholar
  20. Joiner MC, Vojnovic B (1982) Radiofrequency diathermy for uniform heating of mouse tumours. Br J Cancer 45 [Suppl V]: 71–76CrossRefGoogle Scholar
  21. Magin RL, Cysyk RL, Litterst KL (1980) Distribution of adriamycin in mice under conditions of local hyperthermia which improve systemic drug therapy. Cancer Treat Rep 64: 203–210PubMedGoogle Scholar
  22. Malcolm SL, Lee A, Groves JK (1983) High-performance liquid Chromatographic analysis of the new hypoxic-cell radiosensitizer Ro 03-8799, in biological samples. J Chromatogr 273: 327–333PubMedCrossRefGoogle Scholar
  23. Mimnaugh EG, Waring RW, Sikic BI, Magin RL, Drew R, Litterst CL, Gram TE, Guarino AM (1978) Effects of WBH on the disposition and metabolism of adriamycin in rabbits. Cancer Res 38: 1420–1425PubMedGoogle Scholar
  24. Morgan JE, Bleehen NM (1981) Interactions between misonidazole and hyperthermia in EMT6 spheroids. Br J Cancer 44: 810–818PubMedCrossRefGoogle Scholar
  25. Morgan JE, Bleehen NM (1982) Heat sensitivity of EMT6 multicellular tumour spheroids following misonidazole pre-treatment. Natl Cancer Inst Monogr 61: 153–155Google Scholar
  26. Overgaard J (1979) Effects of local hyperthermia on the acute toxicity of misonidazole in mice. Br J Cancer 39: 96–98PubMedCrossRefGoogle Scholar
  27. Overgaard J (1980) Effects of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue. Br J Cancer 41: 10–21PubMedCrossRefGoogle Scholar
  28. Rajaratnam S, Adams GE, Stratford IT, Clarke C (1982) Enhancement of the cytotoxicity of radiosensitizers by modest hyperthermia: the electron-affinity relationship. Br J Cancer 46: 912–917PubMedCrossRefGoogle Scholar
  29. Rauth AM (1984) Pharmacology and toxicology of sensitizers: mechanism studies. Int J Radiat Oncol Biol Phys 10: 1293–1300PubMedCrossRefGoogle Scholar
  30. Roberts JT, Bleehen NM, Walton MI, Workman P (1986) A clinical phase I toxicity study of Ro 03-8799: plasma, urine, tumour and normal brain pharmacokinetics. Br J Radiol 59: 107–116PubMedCrossRefGoogle Scholar
  31. Sathiaseelan V, Har-Kedar I, Howard GCW, Bleehen NM (1983) A microcomputer-controlled microwave hyperthermia system. J Microcomp Appl 6: 261–277CrossRefGoogle Scholar
  32. Smith JM, Robinson S, Pearcy M (1952) Renal responses to exercise, heat and dehydration. J Appl Physiol 4: 659–665PubMedGoogle Scholar
  33. Stratford IJ, Adams GE (1977) Effect of hyperthermia on differential cytotoxicity of a hypoxic cell radiosensitizer, Ro 07-0582, on mammalian cells in vitro. Br J Cancer 35: 307–313PubMedCrossRefGoogle Scholar
  34. Stratford IJ, Watts ME, Adams GE (1978) The effect of hyperthermia on the differential cytotoxicity of some electron-affinic hypoxic cell radiosensitizers on mammalian cells in vitro. Streffer C (ed) Cancer therapy by hyperthermia and radiation. Urban and Schwarzenberg, Munich, pp 267–270Google Scholar
  35. Sutherland RM, Bareham BJ, Reich KA (1980) Cytotoxicity of hypoxic cell sensitizers in multicell spheroids. Cancer Clin Trials 3: 73–83PubMedGoogle Scholar
  36. Walton MI, Bleehen NM, Workman P (1987 a) The effects of whole body hyperthermia on the pharmacokinetics and toxicity of the basic 2-nitroimidazole radiosensitizer Ro 03-8799 in mice. Br J Cancer 55: 469–476PubMedCrossRefGoogle Scholar
  37. Walton MI, Bleehen NM, Workman P (1987 b) Heat stimmulated nitroreductive bioactivation of the 2-introimidazole benzoidazole in vitro. Biochem Pharmacol 36: 2627–2632PubMedCrossRefGoogle Scholar
  38. Watts ME, Jones NR (1985) The effect of extracellular pH on radiosensitization by misonidazole and acidic and basic analogues. Int J Radiat Biol 47,6: 645–653CrossRefGoogle Scholar
  39. White RAS, Workman P (1980) Pharmacokinetic and tumour penetration properties of the hypoxic-cell radiosensitizer desmethylmisonidazole (Ro 05-9963) in dogs. Br J Cancer 41: 268–276PubMedCrossRefGoogle Scholar
  40. Williams MV, Denekamp J, Minchinton AL, Stratford MRL (1982) In vivo assessment of basic 2-nitroimidazole radiosensitizers. Br J Cancer 46: 127–137PubMedCrossRefGoogle Scholar
  41. Wondergem J, Haveman J, van der Schueren E, van der Hoeven H, Breur K (1982) Effect of hyperthermia and misonidazole on the radiosensitivity of a transplantable murine tumour: influence of factors modifying the fraction of hypoxic cells. Int J Radiat Oncol Biol Phys 8: 1323–1331PubMedCrossRefGoogle Scholar
  42. Workman P (1979) Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of misonidazole in mice. Br J Cancer 40: 335–353PubMedCrossRefGoogle Scholar
  43. Workman P (1980) Dose-dependence and related studies on the pharmacokinetics of misonidazole in mice. Cancer Chemother Pharmacol 5: 27–37PubMedCrossRefGoogle Scholar
  44. Workman P, Brown JM (1981) Structure-pharmacokinetic relationships for misonidazole analogues in mice. Cancer Chemother Pharmacol 6: 39–49PubMedCrossRefGoogle Scholar
  45. Workman P, Little CJ, Marten TR, Dale AD, Ruane RJ, Flockhart IR, Bleehen NM (1978) Estimation of the hypoxic cell sensitizer misonidazole and its 0-demethylated metabolite in biological materials by reverse-phase high-performance liquid chromatography. J Chromatogr 145: 507–512PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • N. M. Bleehen
    • 1
  • M. I. Walton
    • 1
  • P. Workman
    • 1
  1. 1.University Department of Clinical Oncology and RadiotherapeuticsThe Medical SchoolCambridgeGreat Britain

Personalised recommendations